SEBI has extended the deadline for its new rule requiring direct credit of securities to clients’ demat accounts to November 11, 2024. The move follows industry feedback to ensure a smooth implementation.
Under this agreement, the parties will commence joint studies to explore the feasibility of Carbon Clean’s CycloneCC modular technology to capture up to 100,000 tonne per year of CO2 emissions — the largest scale CycloneCC deployment to date in steelmaking.…
EBITDA dropped 35.5% to ₹27.8 crore in the second quarter. Shares of Den Networks Ltd ended at ₹52.03, down by ₹0.19, or 0.36%, on the BSE.
In the unlisted market, shares of Garuda Construction are trading flat today. Earlier on October 8, Garuda Construction’s IPO grey market premium (GMP) was recorded at ₹5, or 5.26%, compared to the upper end of the price band.
Zydus Lifesciences received the FDA go-ahead to manufacture paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg. Shares of Zydus Lifesciences Ltd ended at ₹1,055, down by ₹10.15, or 0.95%, on the BSE.
Upcoming state elections in Maharashtra, a key hub for gold manufacturing, are likely to impact purchasing patterns significantly. But that’s not the entire story.
The company’s revenue from operations rose 32.8% to ₹242.5 crore against ₹182.6 crore in the year-ago period. Shares of Anand Rathi Wealth Ltd ended at ₹4,040, down by ₹77.45, or 1.88%, on the BSE.
Post Content
The company has fixed October18, 2024, as the record date for determining the eligibility of shareholders for the purpose and the dividend will be paid out on November 5.
Under the licensing agreement, Alkem will carry out the clinical development of ‘SON-080’ in India with support from Sonnet and enable global and India regulatory filings.